Image Sourced ShutterStock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Roots has secured a total of $1.66 million in funding for investors
  • A$0.070 per share, representing 20 per cent discount to the 30-day VWAP of A$0.0875
  • Roots and Everblu Directors to participate in Placement with investments reaching up to A$600,000
  • RZTO to grow and pursuit of cannabis and hemp opportunities

Roots Sustainable Agricultural Technologies is an Israeli-based agricultural tech-company. Its main focus is to develop, produce and commercialise sustainable technologies which will improve plant performance.

ROO’s plan is to improve crop yield and quality, provide irrigation solutions in a cost-effective and environmentally sustainable way, for plants which othervise cant thrive in difficult weather conditions.

The funds raised will be used to commercialise its Root Zone Temperature Optimisation (RZTO) technology. RZTO influences the root temperatures of plants so they remain at an optimum root zone temperature range. This is essential for a plant’s growth, productivity and quality.

The Company will also use the funds to expand cannabis growers marketing and sales activity in the United States to fund the pursuit of new cannabis and hemp opportunities and to provide working capital.

Roots CEO, Dr Sharon Devir said,  “The placement is a strong endorsement of our substantial opportunities to commercialise our RZTO technology across multiple geographies, as we build on the momentum gained from initial sales. The funding secured in this placement will allow us to accelerate our growth in the US cannabis market, over the medium term.”

ROO by the numbers
More From The Market Online
The Market Online Video

Shekel Brainweigh investor presentation webinar – the future of retail automation

Shekel Brainweigh (ASX:SBW), the retail automation specialists, joins HotCopper for an investor presentation webinar to discuss…
Covid concept ai gen

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Biotron (ASX:BIT) has angered shareholders on HotCopper on Friday as the results of its latest COVID-facing…

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Orthocell (ASX:OCC) has confirmed its sold its first units of collagen-based bone repair product Striate+ in…
Blood test

CLEO Diagnostics kicks off ovarian cancer-detecting blood test trials in USA

Cleo Diagnostics (ASX:COV) has revealed it's kicked off US-based trials sussing the reliability of its blood…